Clicky

Bio-View Ltd(BIOV)

Description: Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company's products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatically scans, analyses, and sorts a range of FISH samples in real-time; and Allegro Plus, an automatic fluorescent imaging system, which identifies various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. It also offers DUET-3, an imaging and analysis platform that include an automated barcode reader, which enables scanning of various test types in a single scan batch; DeNovo, an automated scanning system for detection, analysis, and characterization of circulating tumor cells from peripheral blood; Solo Workstation, an offline workstation that streamlines and enables review and analysis of test results away from the microscope; and SoloWeb, a Web-based solution that provides analysis, reporting, and consulting on BioView-scanned cases. Bio-View Ltd was founded in 2000 and is headquartered in Rehovot, Israel.


Keywords: Biology Imaging Tumor Molecular Biology Laboratory Techniques Pathology Fluorescence Web Based Solution Fluorescence In Situ Hybridization Cytogenetics Allegro Nuclear Organization Scan

Home Page: www.bioview.com

3 Pekeris Street
Rehovot, 7670203
Israel
Phone: 972 73 227 1025


Officers

Name Title
Dr. Alan Schwebel CEO, Pres & Director
Mr. Elad Kfir VP of Marketing
Mr. Yuval Harari M.Sc. Exec. VP
Mr. David Kutas Pres & CEO of Bioview (USA) Inc.
Ms. Yulia Kapon CPA Chief Financial Officer
Ms. Inbal Shmula Hillel VP of Operations

Exchange: TA

Country: IL

Currency: Israeli Agora (ILA)

Forward PE: 0
Trailing PE: 42.1111
Price-to-Book MRQ: 1.7181
Price-to-Sales TTM: 1.7136
IPO Date:
Fiscal Year End: December
Full Time Employees: 35
Back to stocks